Jim Simons Instil Bio, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.63 $89,036 - $140,231	-222,590 Reduced 17.55%	1,045,426 $447,000
Q2 2023 Aug 11, 2023	BUY	$0.51 - $0.67 $229,851 - $301,962	450,690 Added 55.14%	1,268,016 $699,000
Q1 2023 May 12, 2023	SELL	$0.6 - $0.91 $280,260 - $425,061	-467,100 Reduced 36.37%	817,326 $540,000
Q4 2022 Feb 13, 2023	BUY	$0.48 - $5.33 $616,524 - $6.85 Million	1,284,426 New	1,284,426 $809,000
Q2 2022 Aug 12, 2022	BUY	$4.21 - $11.15 $1.49 Million - $3.96 Million	355,035 New	355,035 $1.64 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $8.8B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.